Sonova (OTCMKTS:SONVY) Raised to “Hold” at Jefferies Financial Group

Sonova (OTCMKTS:SONVY) was upgraded by equities researchers at Jefferies Financial Group from a “moderate sell” rating to a “hold” rating in a research report issued on Monday, Zacks reports.

A number of other analysts have also weighed in on SONVY. UBS Group lowered Sonova from a “strong-buy” rating to a “hold” rating in a research note on Monday, November 2nd. Royal Bank Of Canada cut shares of Sonova from a “moderate buy” rating to a “hold” rating in a research report on Friday, November 6th. Citigroup reaffirmed a “sell” rating on shares of Sonova in a research note on Friday, July 24th. Finally, The Goldman Sachs Group raised shares of Sonova from a “hold” rating to a “buy” rating in a research note on Thursday, October 8th. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold”.

Sonova Trading Down 0.1%

Sonova stock opened at $68.21 on Monday. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.75 and a quick ratio of 1.43. The business’s fifty day moving average is $62.84 and its two-hundred day moving average is $53.77. Sonova has a 52 week low of $42.26 and a 52 week high of $71.91.

Sonova Company Profile

Sonova is a Switzerland-based hearing care company headquartered in Stäfa. Founded in 1947 as AG für Elektroakustik, it has grown into a global provider of products and services for people with hearing loss. The company develops and sells hearing aids under brands including Phonak and Unitron, as well as cochlear implant systems through Advanced Bionics. Its offerings also include wireless hearing solutions and consumer audio products sold under the Sennheiser brand. Sonova serves customers worldwide through product sales and audiological care services, including hearing assessments, fittings and ongoing support.